Skip to main content
SinoMab BioScience Limited logo

SinoMab BioScience Limited — Investor Relations & Filings

Ticker · 3681 ISIN · HK0000544194 LEI · 9845009B6CEEC4694006 HKEX Manufacturing
Open in API
Filings indexed 319 across all filing types
Latest filing 2025-06-12 Governance Information
Country HK Hong Kong
Listing HKEX 3681

About SinoMab BioScience Limited

http://www.sinomab.com

SinoMab BioScience Limited is a clinical-stage biopharmaceutical company specializing in the research, development, and commercialization of therapeutic antibodies. The company focuses on developing novel, highly efficacious drugs, including "first-in-class" and "best-in-class" candidates, primarily for the treatment of immunological and life-threatening diseases, such as rheumatoid arthritis. SinoMab maintains full-spectrum drug development capabilities, covering antibody re-engineering, bioprocessing, and manufacturing, aimed at addressing significant unmet medical needs globally.

Recent filings

Filing Released Lang Actions
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Governance Information Classification · 75% confidence The document is an announcement listing the company’s current board composition and the membership of its board committees. It provides details on director roles and the governance committee structure rather than reporting financials or regulatory filings. This matches the definition of Governance Information (CGR).
2025-06-12 English
RESIGNATION OF EXECUTIVE DIRECTOR
Board/Management Information Classification · 95% confidence The document is a corporate announcement titled “Resignation of Executive Director” describing the resignation of Mr. Shanchun Wang from the board and his subsidiaries’ directorships. This clearly falls under a change in the company’s board/senior management. It is not a financial report or regulatory filing announcement, but a board/management update.
2025-06-12 English
POSTPONEMENT AND CHANGE OF VENUE OF ANNUAL GENERAL MEETING AND CHANGE OF BOOK CLOSURE PERIOD
Regulatory Filings Classification · 20% confidence The document is an announcement regarding the postponement and change of venue of the company’s Annual General Meeting and the related book closure period. It is not the AGM presentation materials (AGM-R), nor a full report, proxy statement, or management discussion. It is a corporate announcement provided to comply with listing requirements in Hong Kong, which does not fit into more specific categories, so it falls into the general “Regulatory Filings” fallback category (RNS).
2025-06-11 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Governance Information Classification · 85% confidence The document is an official announcement listing the composition of the Board and its committees, without any indication of new appointments or resignations. It details the company’s board structure and governance roles, fitting the definition of “Governance Information” rather than a change announcement or other category. Therefore, it should be classified as CGR.
2025-06-09 English
PASSING AWAY OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR AND WITHDRAWAL OF ORDINARY RESOLUTION NO. 2(d) AT THE ANNUAL GENERAL MEETING
Board/Management Information Classification · 90% confidence The announcement is a corporate notice regarding the death of an independent non-executive director and resulting changes to board/committee composition, as well as the withdrawal of an AGM resolution tied to that director. This clearly fits under “Board/Management Information,” which covers announcements of changes in the company’s board of directors or senior management. It is not an AGM information pack, a financial report, or a voting results announcement. Therefore, the correct classification is MANG.
2025-06-09 English
VOLUNTARY ANNOUNCEMENT CESSATION TO ACT AS PRESIDENT (CHINA)
Board/Management Information Classification · 93% confidence The announcement relates to the voluntary notification by SinoMab BioScience Limited that Mr. Shanchun Wang will cease to act as President (PRC) effective 6 June 2025. This is a change in senior management, which clearly falls under Board/Management Information. It does not involve financial results, dividends, legal proceedings, or share transactions. Therefore, it is classified as a management change announcement.
2025-06-06 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.